XML 22 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (15,704) $ (10,145)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 53,297 52,271
Amortization of debt issuance costs and debt discount 7,515 7,925
Loss on exchange of 3.25% convertible notes due 2018   1,291
Gain on disposal of assets (2,624) (1,422)
Deferred income taxes (23,061) (12,896)
Stock-based compensation 5,435 5,497
Undistributed equity loss of affiliates 239 75
Other   19
Changes in operating assets and liabilities before effects of business combinations:    
Accounts receivable 14,054 12,341
Inventories 88,450 (1,079)
Derivative financial instruments 1,513 (17,236)
Prepaid expenses and other assets 2,797 (9)
Accounts payable and accrued liabilities (96,295) (74,435)
Current income taxes 10,540 (1,262)
Other (297) 1,322
Net cash provided by (used in) operating activities 45,859 (37,743)
Cash flows from investing activities:    
Purchases of property and equipment, net (14,640) (27,985)
Acquisition of a business, net of cash acquired (1,629) (61,727)
Investments in unconsolidated subsidiaries (2,253) (8,849)
Other investing activities 7,500  
Net cash used in investing activities (11,022) (98,561)
Cash flows from financing activities:    
Proceeds from the issuance of long-term debt 42,300 33,800
Payments of principal on long-term debt (43,370) (66,339)
Proceeds from short-term borrowings 2,089,208 2,149,950
Payments on short-term borrowings (2,158,274) (2,099,929)
Cash payment for exchange of 3.25% convertible notes due 2018   (8,523)
Payments of cash dividends and distributions (20,580) (19,244)
Payments of loan fees (2,622) (1,675)
Payments related to tax withholdings for stock-based compensation (3,013) (3,801)
Proceeds from exercise of stock options 150 50
Net cash used in financing activities (96,201) (15,711)
Net change in cash, cash equivalents and restricted cash (61,364) (152,015)
Cash, cash equivalents and restricted cash, beginning of period 312,360 406,791
Cash, cash equivalents and restricted cash, end of period 250,996 254,776
Reconciliation of total cash, cash equivalents and restricted cash:    
Total cash, cash equivalents and restricted cash 312,360 406,791
Exchange of 3.25% convertible notes due 2018 for shares of common stock   47,743
Exchange of common stock held in treasury stock for 3.25% convertible notes due 2018 1 27,356
Supplemental investing and financing activities:    
Assets acquired in acquisitions and mergers, net of cash 1,629 62,209
Less: liabilities assumed   (482)
Net assets acquired 1,629 61,727
Supplemental disclosures of cash flow    
Cash paid (received) for income taxes (3,163) 1,976
Cash paid for interest $ 36,923 $ 30,314